Form 8-K ImmunoCellular Therapeut For: May 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
ImmunoCellular Therapeutics (IMUC) Tops Q1 EPS by 1c
May 12, 2016 4:59 PM EDTImmunoCellular Therapeutics (NYSE: IMUC) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
... More